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Resources for rare diseases are lacking. Patients do not have the information and support that they need, and
researchers struggle to make progress due to a shortage of skills and collaborations within the field. One way to
overcome these hurdles is to host annual Symposia, focused on a specific rare disease. Here, we use the example of
Birt-Hogg-Dubé Symposia to discuss the practical issues of such meetings, including the importance of timing and
the choice of invited speakers. We highlight the ways in which rare disease symposia can create a single
community, removing barriers between patients, clinicians and researchers.
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There are estimated to be around 7,000 rare diseases,
with 6% of the global population affected by one at some
stage in their life [1]. Despite the high number of people
affected by rare diseases, resources are lacking. Patients
often feel isolated, unable to get the information and
support they need. With so few researchers working in
the rare disease field, support, skills and collaborations
can also be lacking. This inefficient method of research
hinders our understanding of rare diseases and slows the
development of treatments.
With the necessary skills and resources missing, how
can we advance rare disease research and support? One
method is to host scientific and patient meetings. Scien-
tific meetings are an excellent opportunity for research-
ers working in a similar field to come together, learn
about recent advances in the area, foster new collabora-
tions and stimulate new ideas. Here, we discuss the ways
in which such symposia can contribute to and increase
the pace of rare disease research, by using the example
of the BHD Symposia, an annual global meeting orga-
nized by the Myrovlytis Trust.
Birt-Hogg-Dubé (BHD) Syndrome is a rare genetic dis-
order characterized by benign skin tumors, lung cysts
leading to pneumothorax and an increased risk for renal* Correspondence: vicki@myrovlytistrust.org
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distribution, and reproduction in any mediumcell carcinoma [2,3]. Patients can develop any combin-
ation of the symptoms, making diagnosis difficult and
meaning that BHD is probably under diagnosed [4]. As
such, it is important to raise awareness of BHD among
patients and clinicians. The Myrovlytis Trust, a medical
charity focusing on rare genetic diseases, funds research
into BHD syndrome and organizes annual symposia,
uniting the BHD community. Four International BHD
Symposia have taken place since 2008, bringing together
researchers, clinicians and patients. Each Symposium has
grown in the number of delegates, with the Fourth BHD
Symposium, held in March 2012, hosting over 90 atten-
dees, about a third of whom were patients and family
members.
As with all scientific meetings, sharing unpublished
data and discussing ideas is key to making rapid progress
in the field. However, for rare diseases, the importance of
symposia extends beyond that of standard scientific
meetings. With so few individuals studying the disease,
symposia are important for generating a community feel.
Researchers are often geographically isolated and find it
difficult to form strong collaborations. Symposia are the
perfect opportunity for scientists from across disciplines
to meet and share their skills.
BHD researchers are located all across the world, but
often with only one or two institutions in each country
involved in BHD research. BHD Symposia mitigate theentral Ltd. This is an Open Access article distributed under the terms of the
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sources of help and motivation. The Symposia also allow
BHD researchers to meet, discuss challenges and ideas
and form new collaborations.
As many BHD patients do not know anyone else with
BHD outside their own family, it is valuable to bring
patients together to share stories, ask advice and jump-
start peer support. The BHD Symposia are joint meet-
ings for researchers and patients, with both mixed and
separate sessions. The aim of the Symposia is to generate
the sense of a single BHD community, removing barriers
between patients, family members, scientists and
clinicians.
Awareness of BHD amongst the wider research com-
munity is central to making progress in understanding
the disease. Attracting new researchers to the field would
bring in new skills and resources, as well as a fresh per-
spective on research. Awareness can be achieved through
widely advertising the symposium, but also by careful se-
lection of the invited speakers and the timing of the
meeting.
As well as inviting experts from within the BHD field
to speak at the BHD Symposia, other world-class
researchers are also invited who could speak on a
broader topic. This may attract scientists who would not
normally have considered attending and thereby raise
awareness of BHD. Holding the Symposium adjacent to
another scientific meeting may also help to attract atten-
dees as it would save on travelling time and cost. For the
BHD Symposia, previous meetings have been held adja-
cent to a related rare disease symposium (the 8th Inter-
national Medical Symposium on von Hippel-Lindau
disease) and, in 2010 and 2012, the American Associ-
ation for Cancer Research (AACR) Annual Meeting.
The BHD Symposia is the only meeting anywhere in
the world dedicated entirely to BHD Syndrome, and as
such, all researchers who work on BHD are likely to at-
tend. This contributes significantly to the success of the
symposia and helps to stimulate research. The format
described here for BHD Symposia can be replicated for
any rare disease and we hope, with time, that more rare
diseases can be represented by such meetings. There is
currently an increasing interest into rare diseases, with
charities such as Findacure being launched in the UK
this year. Now is an exciting time to push rare disease
research forward and get more people involved in the
field.
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